Search Results - "Zbroch, Edyta"

Refine Results
  1. 1

    Mid-Regional Proadrenomedullin in COVID-19-May It Act as a Predictor of Prolonged Cardiovascular Complications? by Pietraszko, Paulina, Zorawski, Marcin, Bielecka, Emilia, Sielatycki, Piotr, Zbroch, Edyta

    “…The rising prevalence of cardiovascular disease (CVD) and the impact of the SARS-CoV-2 pandemic have both led to increased mortality rates, affecting public…”
    Get full text
    Journal Article
  2. 2

    Elevated Arterial Blood Pressure as a Delayed Complication Following COVID-19-A Narrative Review by Bielecka, Emilia, Sielatycki, Piotr, Pietraszko, Paulina, Zapora-Kurel, Agnieszka, Zbroch, Edyta

    “…Arterial hypertension is one of the most common and significant cardiovascular risk factors. There are many well-known and identified risk factors for its…”
    Get full text
    Journal Article
  3. 3

    The Links between Microbiome and Uremic Toxins in Acute Kidney Injury: Beyond Gut Feeling-A Systematic Review by Rydzewska-Rosołowska, Alicja, Sroka, Natalia, Kakareko, Katarzyna, Rosołowski, Mariusz, Zbroch, Edyta, Hryszko, Tomasz

    Published in Toxins (11-12-2020)
    “…The last years have brought an abundance of data on the existence of a gut-kidney axis and the importance of microbiome in kidney injury. Data on kidney-gut…”
    Get full text
    Journal Article
  4. 4

    Sirtuin 1 and Skin: Implications in Intrinsic and Extrinsic Aging-A Systematic Review by Bielach-Bazyluk, Angelika, Zbroch, Edyta, Mysliwiec, Hanna, Rydzewska-Rosolowska, Alicja, Kakareko, Katarzyna, Flisiak, Iwona, Hryszko, Tomasz

    Published in Cells (Basel, Switzerland) (06-04-2021)
    “…Skin, as the outermost organ of the body, is constantly exposed to both intrinsic and extrinsic causative factors of aging. Intrinsic aging is related to…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Circulating renalase, catecholamines, and vascular adhesion protein 1 in hypertensive patients by Maciorkowska, Dominika, Zbroch, Edyta, Malyszko, Jolanta

    “…The aim of the study was to estimate and correlate circulating levels of renalase, vascular adhesion protein-1 (VAP-1), catecholamines in patients with primary…”
    Get more information
    Journal Article
  7. 7

    Renalase is removed by kidneys and during dialysis - excess related to CKD complications? by Malyszko, Jolanta, Koc-Zorawska, Ewa, Zorawski, Marcin, Kozminski, Piotr, Zbroch, Edyta, Rysz, Jacek, Banach, Maciej, Malyszko, Jacek S

    Published in Current vascular pharmacology (01-01-2015)
    “…The most common complications of chronic kidney disease (CKD) are hypertension and cardiovascular (CV) disorders. Renalase is produced and released by the…”
    Get more information
    Journal Article
  8. 8

    COVID-19 AND CARDIOVASCULAR COMPLICATIONS. AN INAUSPICIOUS COMBINATION by Zbroch, Edyta, Waszak, Julia, Siwik, Marcin, Bazarewicz, Jakub, Piotrowska, Weronika, Sielatycki, Piotr

    Published in Journal of hypertension (01-06-2023)
    “…Objective: The case report presents patient with COVID-19 history. Although the course of COVID-19 in most people is mild, most cases, including severe ones,…”
    Get full text
    Journal Article
  9. 9

    FROM A SYNCOPE TO MYOCARDITIS - AN UNUSUAL MANIFESTATION OF MYOCARDITIS IN OBESE PATIENT WITH HYPERTENSION AND PARANOIDAL SCHIZOPHRENIA by Zbroch, Edyta, Wawiernia, Julia, Zbroch, Aleksandra, Zalewska, Aleksandra, Baranowska, Magdalena, Sielatycki, Piotr

    Published in Journal of hypertension (01-06-2023)
    “…Objective: The case report presents a 30-year-old obese patient with a history of paranoidal schizophrenia, sinus tachycardia and hypertension which was…”
    Get full text
    Journal Article
  10. 10

    Cardiovascular risk in chronic kidney disease: what is new in the pathogenesis and treatment? by Bazyluk, Angelika, Malyszko, Jolanta, Zbroch, Edyta

    Published in Postgraduate medicine (04-07-2018)
    “…The prevalence of chronic kidney disease (CKD) has increased markedly over past decades due to the aging of the worldwide population. Despite the progress in…”
    Get full text
    Journal Article
  11. 11

    STAY ALERT ABOUT COAGULATION PARAMETERS - IMPLICATIONS OF THROMBOSIS TREATMENT IN COVID-19 by Sielatycki, Piotr, Zbroch, Edyta, Markowska, Martyna, Zalewska, Aleksandra, Bowtruczuk, Aleksandra, Warpecowski, Jedrzej, Gryciuk, Malgorzata

    Published in Journal of hypertension (01-06-2022)
    “…Objective: The case report presents two patients with COVID-19 history. The first patient, treated with enoxaparin, was diagnosed with pulmonary embolism, and…”
    Get full text
    Journal Article
  12. 12

    WHEN PERCUTANEOUS CORONARY INTERVENTION (PCI) IS NOT AN OPTION - CONSERVATIVE TREATMENT OF STEMI DUE TO THE CONTRAINDICATIONS AND SEVERE COVID-19 INFECTION by Zbroch, Edyta, Adasko, Grzegorz, Cabaj, Marta, Barano, Magdalena, Zbroch, Aleksandra, Wawiernia, Julia, Zalewska, Aleksandra, Zapora-Kurel, Agnieszka

    Published in Journal of hypertension (01-06-2023)
    “…Objective: The case report presents patient with the history of ST-segment elevation myocardial infarction (STEMI) and COVID-19 infection. STEMI is one of the…”
    Get full text
    Journal Article
  13. 13
  14. 14

    WORLD HYPERTENSION DAY 2023 – THE PRO-HEALTH CAMPAIGN IN BIALYSTOK, POLAND by Piotrowska, Weronika, Gawryluk, Mateusz, Zbroch, Aleksandra, Bazarewicz, Jakub, Anikie, Katarzyna, Malinowska, Dominika, Skorulska, Iwona, Siwik, Marcin, Panas, Zuzanna, Szczerbinska, Natalia, Zdanska, Adrianna, Wilk-sledziewska, Katarzyna, Zbroch, Edyta

    Published in Journal of hypertension (01-05-2024)
    “…Objective: The study was based on a pro-health campaign of World Hypertension Day 2023. The aim of the study was to evaluate the incidental blood pressure…”
    Get full text
    Journal Article
  15. 15

    MID-REGIONAL PROADRENOMEDULLIN (MR-PROADM) AS A BIOMARKER IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERTENSION - STUDY CONTINUATION by Czajkowska, Katarzyna, Zbroch, Edyta, Bielach-Bazyluk, Angelika, Koc-Zorawska, Ewa, Kakareko, Katarzyna, Rydzewska-Rosolowska, Alicja, Hryszko, Tomasz

    Published in Journal of hypertension (01-06-2022)
    “…Objective: Assessment of MR-proADM serum concentration as a biomarker in patients with CKD and arterial hypertension. Design and method: Our study included a…”
    Get full text
    Journal Article
  16. 16

    Endocan Concentration in Patients With Primary Hypertension by Musialowska, Dominika, Zbroch, Edyta, Koc-Zorawska, Ewa, Musialowski, Piotr, Malyszko, Jolanta

    Published in Angiology (01-07-2018)
    “…Inflammation and endothelial dysfunction may play an important role in the multifactorial pathogenesis of hypertension. Endocan is also thought to play a role…”
    Get full text
    Journal Article
  17. 17

    State of the art – sirtuin 1 in kidney pathology – clinical relevance by Bazyluk, Angelika, Malyszko, Jolanta, Hryszko, Tomasz, Zbroch, Edyta

    Published in Advances in medical sciences (01-09-2019)
    “…Sirtuins represent a group of nicotinamide adenine dinucleotide dependent histone deacetylases, which regulates various biological pathways by promoting…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    PROGNOSTIC VALUE OF MID-REGIONAL PROADRENOMEDULLIN (MR-PROADM) IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERTENSION by Czajkowska, Katarzyna, Zbroch, Edyta, Bielach-Bazyluk, Angelika, Koc-Zorawska, Ewa, Kakareko, Katarzyna, Rydzewska-Rosolowska, Alicja, Hryszko, Tomasz

    Published in Journal of hypertension (01-04-2021)
    “…Objective: Adrenomedullin (ADM) is a peptide hormone with an antihypertensive effect. ADM plasma concentration is elevated in hypertension, heart failure and…”
    Get full text
    Journal Article